Biotech Values

[DewDiligence]

Frank: the Lomucin results were not bad. But there was insufficient evidence to say that they were good.

To use a courtroom analogy: if you were on the jury you would certainly not vote to convict. However, you were not fully convinced that the defendant was innocent. What you really wanted to do was vote “not proven” (which I have heard is a juror’s prerogative at criminal trials in Scotland).

--
I think Lomucin is on temporary hold until GENR’s money situation becomes clarified. When we get a partnership for Squalamine, the up-front cash may be sufficient to restart the Lomucin program, with or without continued funding from the CF Foundation. JMHO. Dew